GoHealth (GOCO) Receives a Buy from Raymond James


In a report released yesterday, Charles Peters from Raymond James maintained a Buy rating on GoHealth (GOCO). The company’s shares closed last Wednesday at $13.33.

According to TipRanks.com, Peters is a 5-star analyst with an average return of 9.8% and a 68.9% success rate. Peters covers the Financial sector, focusing on stocks such as Argo Group International Holdings, American Equity Investment Life, and Hallmark Financial Services.

GoHealth has an analyst consensus of Strong Buy, with a price target consensus of $21.67.

See today’s analyst top recommended stocks >>

The company has a one-year high of $26.25 and a one-year low of $10.02. Currently, GoHealth has an average volume of 1.18M.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

GoHealth Inc is a health insurance marketplace in America. Its technology platform leverages modern machine-learning algorithms and helps individuals find the best health insurance plan for their specific needs. The company operates in four segments: Medicare-Internal; Medicare-External, IFP and Other-Internal; and IFP and Other-External. The Medicare segments sales Medicare Advantage, Medicare Supplement, Medicare prescription drug plans, and Medicare Special Needs Plans.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts